Dr David Perrick, MD, | |
One Richland Medical Park, Suite 200 Carolina Allergy And Asthma Consultants, Columbia, SC 29203 | |
(803) 765-9233 | |
(803) 779-9344 |
Full Name | Dr David Perrick |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | One Richland Medical Park, Columbia, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336255280 | NPI | - | NPPES |
143179 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 14317 (South Carolina) | Primary |
Entity Name | Carolina Allergy & Asthma Consultants |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285723593 PECOS PAC ID: 3173650876 Enrollment ID: O20100429000493 |
News Archive
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Experts in Sweden are warning that the new U.S. recommendations for lowering cholesterol levels would increase the risk of harmful side effects with no overall reduction in deaths.
Overweight or obese adolescents who were spoken to about their weight by their mothers and fathers were more likely to engage in binge eating and use unhealthy weight-control behaviors than teens whose parents spoke with them in terms of eating healthier, according to a study published in JAMA Pediatrics.
Researchers from the Center for Translational Medicine at Thomas Jefferson University have found that the overexpression of a sodium/calcium exchanger, without changes in other ion transport pathways commonly observed in heart failure, does not by itself lead to contraction abnormalities in the heart.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Perrick, MD, One Richland Medical Park, Suite 200 Carolina Allergy And Asthma Consultants, Columbia, SC 29203 Ph: (803) 765-9233 | Dr David Perrick, MD, One Richland Medical Park, Suite 200 Carolina Allergy And Asthma Consultants, Columbia, SC 29203 Ph: (803) 765-9233 |
News Archive
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Experts in Sweden are warning that the new U.S. recommendations for lowering cholesterol levels would increase the risk of harmful side effects with no overall reduction in deaths.
Overweight or obese adolescents who were spoken to about their weight by their mothers and fathers were more likely to engage in binge eating and use unhealthy weight-control behaviors than teens whose parents spoke with them in terms of eating healthier, according to a study published in JAMA Pediatrics.
Researchers from the Center for Translational Medicine at Thomas Jefferson University have found that the overexpression of a sodium/calcium exchanger, without changes in other ion transport pathways commonly observed in heart failure, does not by itself lead to contraction abnormalities in the heart.
› Verified 9 days ago
Dr. Michael J Bykowsky, MD PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1 Richland Medical Park Dr Ste 200, Carolina Allergy And Asthma Consultants, Columbia, SC 29203 Phone: 803-765-9233 Fax: 803-779-0344 | |
Lawrence S Weiner, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: One Richland Medical Park, Ste 200 Carolina Allergy & Asthma Consultants, Columbia, SC 29203 Phone: 803-765-9233 Fax: 803-779-0344 | |
Lisa S Hutto, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: Ste 430, 9 Richland Medical Pk, Columbia, SC 29203 Phone: 803-765-9435 Fax: 803-765-2446 | |
Jonathan Black, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1 Richland Medical Park Dr, Suite 200, Columbia, SC 29203 Phone: 803-765-9233 Fax: 803-779-0344 | |
Vernishia Robinson, D.C. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1531 Blanding St, Columbia, SC 29201 Phone: 803-466-6696 | |
Mrs. Thelisa Y Sulton, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 201 Columbia Mall Blvd Ste 189, Columbia, SC 29223 Phone: 803-602-5570 Fax: 888-958-0279 |